Related Experiment Video
Updated: Jun 3, 2026
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
Clinical features and efficacy analysis of idiopathic sudden sensorineural hearing loss in children: a single-center,
1Department of ENT and Head & Neck Surgery, The Children's Hospital Zhejiang University School of Medicine, National Clinical Research Center For Children And Adolescents' Health and Diseases, Binsheng Road 3333, Hangzhou, Zhejiang, 310051, China.
Purpose:
To summarize the clinical features, therapeutic effects, and related influencing factors of idiopathic sudden sensorineural hearing loss (ISSNHL) in children to optimize the clinical management plan for this disease.
Methods:
A retrospective analysis was performed on the clinical data of 267 children with ISSNHL (318 ears) aged 5-18 years who were admitted to a single center between August 2015 and August 2025. An individualized comprehensive treatment regimen was adopted, and the primary efficacy endpoint was the hearing level 3 months after treatment. Correlation analysis was conducted to explore the associations between the therapeutic effect and different factors.
Results:
Children aged 8-12 years old accounted for the highest proportion of cases (72.3%). Moderate-to-severe hearing loss was the main type of hearing impairment (85.3%), with total deafness accounting for 29.2% of cases. Tinnitus and vertigo were the most common accompanying symptoms. Patients aged 8-18 years old had better therapeutic outcomes than those aged 5-7 years old. Patients with accompanying tinnitus and vertigo had the best and worst therapeutic outcomes, respectively. A significant improvement in efficacy was observed when treatment was initiated within 7 days of onset. No significant correlations were found between the therapeutic effect and the time from onset to treatment or the affected ear.
Conclusion:
Individualized comprehensive treatment can improve the prognosis of children with ISSNHL, and stratified treatment strategies should be formulated for different patient populations.
